Company profile ORIC
After 39 days of this quarter the interest is at 64.0. Based on that we can calculate that during remaining 52 days it will total up to 149.0. ORIC Pharmaceuticals expected interest is significantly higher compared to previous quarter (+122.4%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 73 | 76 4.1% QoQ | 49 -35.5% QoQ | 76 55.1% QoQ |
| 2020 | 96 31.5% YoY 26.3% QoQ | 265 248.7% YoY 176.0% QoQ | 105 114.3% YoY -60.4% QoQ | 81 6.6% YoY -22.9% QoQ |
| 2021 | 83 -13.5% YoY 2.5% QoQ | 94 -64.5% YoY 13.3% QoQ | 128 21.9% YoY 36.2% QoQ | 165 103.7% YoY 28.9% QoQ |
| 2022 | 105 26.5% YoY -36.4% QoQ | 103 9.6% YoY -1.9% QoQ | 32 -75.0% YoY -68.9% QoQ | 78 -52.7% YoY 143.8% QoQ |
| 2023 | 120 14.3% YoY 53.8% QoQ | 90 -12.6% YoY -25.0% QoQ | 102 218.8% YoY 13.3% QoQ | 67 -14.1% YoY -34.3% QoQ |
| 2024 | 64 -46.7% YoY -4.5% QoQ | - | - | - |
The average 5 years interest of ORIC Pharmaceuticals was 7.86 per week. The last year interest of ORIC Pharmaceuticals compared to the last 5 years has changed by -5.6%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 13.11%.
There is not enough data for ORIC Pharmaceuticals login to provide analysis
There is not enough data for ORIC Pharmaceuticals login to provide correlation calculation
There is not enough data for ORIC Pharmaceuticals login to provide analysis
After 39 days of this quarter the interest is at 41.0. Based on that we can calculate that during remaining 52 days it will total up to 96.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 14 | 64 357.1% QoQ | 132 106.2% QoQ | 55 -58.3% QoQ |
| 2020 | 85 507.1% YoY 54.5% QoQ | 172 168.8% YoY 102.4% QoQ | 178 34.8% YoY 3.5% QoQ | 109 98.2% YoY -38.8% QoQ |
| 2021 | 32 -62.4% YoY -70.6% QoQ | 181 5.2% YoY 465.6% QoQ | 140 -21.3% YoY -22.7% QoQ | 179 64.2% YoY 27.9% QoQ |
| 2022 | 65 103.1% YoY -63.7% QoQ | 29 -84.0% YoY -55.4% QoQ | 18 -87.1% YoY -37.9% QoQ | 91 -49.2% YoY 405.6% QoQ |
| 2023 | 105 61.5% YoY 15.4% QoQ | 71 144.8% YoY -32.4% QoQ | 132 633.3% YoY 85.9% QoQ | 98 7.7% YoY -25.8% QoQ |
| 2024 | 41 -61.0% YoY -58.2% QoQ | - | - | - |
The average 5 years interest of ORIC Pharmaceuticals stock was 7.63 per week. The last year interest of ORIC Pharmaceuticals stock compared to the last 5 years has changed by -9.83%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 34.9%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. ORIC Pharmaceuticals news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 0 | 88 inf% QoQ | 39 -55.7% QoQ |
| 2020 | 135 inf% YoY 246.2% QoQ | 79 inf% YoY -41.5% QoQ | 114 29.5% YoY 44.3% QoQ | 72 84.6% YoY -36.8% QoQ |
| 2021 | 72 -46.7% YoY 0.0% QoQ | 45 -43.0% YoY -37.5% QoQ | 65 -43.0% YoY 44.4% QoQ | 120 66.7% YoY 84.6% QoQ |
| 2022 | 98 36.1% YoY -18.3% QoQ | 24 -46.7% YoY -75.5% QoQ | 20 -69.2% YoY -16.7% QoQ | 223 85.8% YoY 1015.0% QoQ |
| 2023 | 57 -41.8% YoY -74.4% QoQ | 52 116.7% YoY -8.8% QoQ | 111 455.0% YoY 113.5% QoQ | 131 -41.3% YoY 18.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of ORIC Pharmaceuticals news was 5.92 per week. The last year interest of ORIC Pharmaceuticals news compared to the last 5 years has changed by 3.38%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 31.61%.
There is not enough data for ORIC Pharmaceuticals clinical trials to provide analysis
There is not enough data for ORIC Pharmaceuticals clinical trials to provide correlation calculation
There is not enough data for ORIC Pharmaceuticals clinical trials to provide analysis
There is not enough data for ORIC Pharmaceuticals cancer treatments to provide analysis
There is not enough data for ORIC Pharmaceuticals cancer treatments to provide correlation calculation
There is not enough data for ORIC Pharmaceuticals cancer treatments to provide analysis
There is not enough data for ORIC Pharmaceuticals pipeline to provide analysis
There is not enough data for ORIC Pharmaceuticals pipeline to provide correlation calculation
There is not enough data for ORIC Pharmaceuticals pipeline to provide analysis
There is not enough data for ORIC Pharmaceuticals CEO to provide analysis
There is not enough data for ORIC Pharmaceuticals CEO to provide correlation calculation
There is not enough data for ORIC Pharmaceuticals CEO to provide analysis
There is not enough data for ORIC Pharmaceuticals headquarters to provide analysis
There is not enough data for ORIC Pharmaceuticals headquarters to provide correlation calculation
There is not enough data for ORIC Pharmaceuticals headquarters to provide analysis